Novo Nordisk CEO Senate Hearing

This is a Washington news story, published by CNBC, that relates primarily to Lars Fruergaard Jørgensen news.

Washington news

For more Washington news, you can click here:

more Washington news

Lars Fruergaard Jørgensen news

For more Lars Fruergaard Jørgensen news, you can click here:

more Lars Fruergaard Jørgensen news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Novo Nordisk CEO Lars Fruergaard Jørgensen

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Danish drugmaker news, Senate Health news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Novo Nordisk

CNBC

•

Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

Summary

Nutrition label

84% Informative

Danish drugmaker's CEO Lars Fruergaard Jørgensen will testify at a Senate Health, Education , Labor and Pensions Committee hearing at 10 a.m. ET on Tuesday in Washington , D.C. Sen. Bernie Sanders , who chairs the Senate panel, argues that Novo Nordisk charges Americans substantially higher prices for its blockbuster injections than it does for patients in other countries.